Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization

被引:17
作者
Andersen, CL
Gruszka-Westwood, A
Atkinson, S
Matutes, E
Catovsky, D
Pedersen, RK
Pedersen, BB
Pulczynski, S
Hokland, P
Jacobsen, E
Koch, J
机构
[1] Arhus Sygehus, Dept Hematol, Lab Canc Cytogenet, DK-8000 Aarhus C, Denmark
[2] Royal Marsden Hosp, Canc Res Inst, Acad Dept Haematol & Cytogenet, London SW3 6JJ, England
[3] Odense Univ Hosp, Inst Pathol, Chromosome Lab, DK-5000 Odense C, Denmark
[4] Viborg Hosp, Dept Med, Viborg, Denmark
[5] Holstebro Centralgehus, Dept Med, Holstebro, Denmark
[6] Arhus Sygehus, Dept Hematol, Lab Immunohematol, Aarhus C, Denmark
[7] Skejby Sygehus, Dept Clin Biochem, Mol Diagnost Lab, Aarhus C, Denmark
[8] Inst Canc Res, Leukemia Res Fdn Ctr Cell & Mol Biol Childhood Le, London SW3 6JB, England
[9] Arhus Sygehus, Inst Pathol, Aarhus C, Denmark
关键词
D O I
10.1016/j.cancergencyto.2004.04.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cytogenetics of splenic marginal zone lymphoma (SMZL) is less well characterized than the cytogenetics of other non-Hodgkin B-cell lymphomas. The aim of this study was to address this issue by identifying characteristic copy number imbalances in SMZL, for which purpose we analyzed 20 SMZL cases by comparative genomic hybridization (CGH), adding chromosome banding and fluorescence in situ hybridization (FISH) in some cases. CGH identified copy number imbalances in 70% of the cases. Imbalances were recurrently observed for chromosomes 3 (20%), 6 (20%), 7 (25%), 12 (20%), and 14 (10%). The minimally involved regions of these chromosomes were gains of 3q25similar toqter and 12q13-q15, and loss of 6q23, 7q31, and 14q22similar toq24. A compilation of our data with data from 3 previous SMZL CGH studies revealed a significant heterogeneity between the studies. Eleven imbalances were recurrently observed in the compiled data set, as opposed to only 5 in our data set. The most frequently observed imbalances in the 73 SMZL cases of the compiled data set were gains of 3q (27%) and 12q (15%), and loss of 7q (18%). Our data suggest that SMZL constitute a genetically heterogeneous disease where gain of 3q25 and loss of 7q31 are the most likely imbalances to be involved in the pathogenesis of the disease. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:122 / 128
页数:7
相关论文
共 19 条
[1]   Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32 [J].
Boonstra, R ;
Bosga-Bouwer, A ;
van Imhoff, GW ;
Krause, V ;
Palmer, M ;
Coupland, RW ;
Dabbagh, L ;
van den Berg, E ;
van den Berg, A ;
Poppema, S .
MODERN PATHOLOGY, 2003, 16 (12) :1210-1217
[2]  
Brito-Babapulle V, 2002, HAEMATOLOGICA, V87, P357
[3]  
Brynes RK, 1996, MODERN PATHOL, V9, P995
[4]   Integration of cytogenetic landmarks into the draft sequence of the human genome [J].
Cheung, VG ;
Nowak, N ;
Jang, W ;
Kirsch, IR ;
Zhao, S ;
Chen, XN ;
Furey, TS ;
Kim, UJ ;
Kuo, WL ;
Olivier, M ;
Conroy, J ;
Kasprzyk, A ;
Massa, H ;
Yonescu, R ;
Sait, S ;
Thoreen, C ;
Snijders, A ;
Lemyre, E ;
Bailey, JA ;
Bruzel, A ;
Burrill, WD ;
Clegg, SM ;
Collins, S ;
Dhami, P ;
Friedman, C ;
Han, CS ;
Herrick, S ;
Lee, J ;
Ligon, AH ;
Lowry, S ;
Morley, M ;
Narasimhan, S ;
Osoegawa, K ;
Peng, Z ;
Plajzer-Frick, I ;
Quade, BJ ;
Scott, D ;
Sirotkin, K ;
Thorpe, AA ;
Gray, JW ;
Hudson, J ;
Pinkel, D ;
Ried, T ;
Rowen, L ;
Shen-Ong, GL ;
Strausberg, RL ;
Birney, E ;
Callen, DF ;
Cheng, JF ;
Cox, DR .
NATURE, 2001, 409 (6822) :953-958
[5]   Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations [J].
Corcoran, MM ;
Mould, SJ ;
Orchard, JA ;
Ibbotson, RE ;
Chapman, RM ;
Boright, AP ;
Platt, C ;
Tsui, LC ;
Scherer, SW ;
Oscier, DG .
ONCOGENE, 1999, 18 (46) :6271-6277
[6]   Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization [J].
Dierlamm, J ;
Rosenberg, C ;
Stul, M ;
Pittaluga, S ;
Wlodarska, I ;
Michaux, L ;
Dehaen, M ;
Verhoef, G ;
Thomas, J ;
deKelver, W ;
BakkerSchut, T ;
Cassiman, JJ ;
Raap, AK ;
DeWolfPeeters, C ;
VandenBerghe, H ;
Hagemeijer, A .
LEUKEMIA, 1997, 11 (05) :747-758
[7]   BCL6 gene rearrangements also occur in marginal zone B-cell lymphoma [J].
Dierlamm, J ;
Pittaluga, S ;
Stul, M ;
Wlodarska, I ;
Michaux, L ;
Thomas, J ;
Verhoef, G ;
Verhest, A ;
Depardieu, C ;
Cassiman, JJ ;
Hagemeijer, A ;
DeWolfPeeters, C ;
VandenBerghe, H .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (03) :719-725
[8]   The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH [J].
Gruszka-Westwood, AM ;
Matutes, E ;
Coignet, LJA ;
Wotherspoon, A ;
Catovsky, D .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (03) :600-604
[9]  
HARRIS NL, 1994, BLOOD, V84, P1361
[10]   Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics [J].
Hernández, JN ;
García, JL ;
Gutiérrez, NC ;
Mollejo, M ;
Martínez-Climent, JA ;
Flores, T ;
González, MB ;
Piris, MA ;
Miguel, JFS .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (05) :1843-1850